Jazz Pharmaceuticals plc — Director's Dealing 2011

Dec 16, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2011-12-14

Reporting Person: SEBULSKY ALAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-14	Common Stock	M	9036	$15.09	Acquired	37288	Direct
2011-12-14	Common Stock	F	3896	$34.99	Disposed	33392	Direct
2011-12-14	Common Stock	M	17500	$18.00	Acquired	50892	Direct
2011-12-14	Common Stock	F	9002	$34.99	Disposed	41890	Direct
2011-12-14	Common Stock	M	10000	$12.75	Acquired	51890	Direct
2011-12-14	Common Stock	F	3643	$34.99	Disposed	48247	Direct
2011-12-14	Common Stock	M	10000	$7.84	Acquired	58247	Direct
2011-12-14	Common Stock	F	2240	$34.99	Disposed	56007	Direct
2011-11-23	Common Stock	G	1252	—	Disposed	54755	Direct
2011-12-15	Common Stock	G	400	—	Disposed	54355	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-14	Option (right to buy)	$15.09	M	9036	Disposed	2014-09-14	Common Stock (9036)	Direct
2011-12-14	Option (right to buy)	$18.00	M	17500	Disposed	2017-05-30	Common Stock (17500)	Direct
2011-12-14	Option (right to buy)	$12.75	M	10000	Disposed	2017-08-14	Common Stock (10000)	Direct
2011-12-14	Option (right to buy)	$7.84	M	10000	Disposed	2018-08-14	Common Stock (10000)	Direct

Footnotes

F1: Represents shares withheld by the Issuer for cashless exercise of options.

F2: The option had a vesting schedule of one fourth vested on July 13, 2005, one fourth vested on July 13, 2006, one fourth vested on July 13, 2007 and the remainder vested on July 13, 2008.

F3: The option had a vesting schedule of one third vested on May 31, 2008 and the remainder vested in 24 equal monthly installments thereafter.

F4: The option vested in 12 equal monthly installments from August 15, 2007.

F5: The option vested in 12 equal monthly installments from August 15, 2008.